Tumor-induced thymic atrophy: Alteration in interferons and Jak/Stats signaling pathways

Roberto Carrio, Marta Torroella-Kouri, Vijaya Iragavarapu-Charyulu, Diana M. Lopez

Research output: Contribution to journalArticlepeer-review

13 Scopus citations


The thymus is the major site of T cell differentiation and a key organ of the immune system. Thym atrophy has been observed in several model systems including aging, and tumor development. Previous results from our laboratory have reported that the thymic atrophy seen in mammary tumor bearers is associated with a severe depletion of CD4+CD8+ double positive immature cells and changes in the levels of cytokines expressed in the thymus microenvironment. Cytokines regulate numerous aspects of hematopoiesis via activation of the Jak/Stat pathways. In the present study we have used our mammary tumor model to investigate whether changes in the levels of cytokines in the thymus could affect the normal expression of the aforementioned pathways. RNA and protein analysis revealed an overexpression of the different members of interferons, a downregulation of most of the Jak/Stat pathways, and an increased expression of several suppressors of cytokine signaling (SOSC) in the thymuses of tumor bearers. Together, our data suggest that the impaired Jak/Stat signaling pathways observed in the whole thymus of tumor-bearing mice could be contributing to the abnormal T cell development and apoptosis observed during the tumor-induced thymic atrophy.

Original languageEnglish (US)
Pages (from-to)547-553
Number of pages7
JournalInternational journal of oncology
Issue number2
StatePublished - Feb 2011


  • Interferons
  • Jak/Stat pathways
  • Thymus atrophy
  • Tumor-bearing mice

ASJC Scopus subject areas

  • Cancer Research
  • Oncology


Dive into the research topics of 'Tumor-induced thymic atrophy: Alteration in interferons and Jak/Stats signaling pathways'. Together they form a unique fingerprint.

Cite this